Terms Unconditional

F500 Pharma & Biotech · Health Care: Pharmacy and Other Services · Structural / no discrete incident

IQVIA

Headline

IQVIA is the row on this tab that deserves the most attention and generates the least public record, which is itself the finding.

Not independently verified. Verification status: Unverified - heuristic first draft. Publish state: draft unverified.

IQVIA is the row on this tab that deserves the most attention and generates the least public record, which is itself the finding. It is a health-data and clinical-research company whose business is aggregating and analysing prescription, claims and electronic-health-record data at population scale, licensed onward to pharmaceutical companies and others. Because that data is handled as de-identified, most of it falls outside HIPAA's protections entirely - HIPAA governs identified protected health information held by covered entities, and a data aggregator working with de-identified datasets sits largely outside that perimeter. So the company with arguably the deepest view of American prescribing behaviour is also the one a patient has the least ability to see, question or opt out of. Specific figures were not independently verified this pass and none are asserted; recommend a direct follow-up focused on the de-identification and re-identification-risk question.

  • SeveritySeverity 2 of 5, not independently verified. IQVIA is the row on this tab that deserves the most attention and generates the least public record, which is itself the finding.
  • Evidence tierUnassigned
  • Claims confirmedNo sourced claims yet
  • Last verified2026-08-04

Primary source. None recorded — Unverified - heuristic first draft.

Last verified 96 days agoverified 96 days ago0180 days
Freshness. Last verified 96 days ago (2026-08-04); stale after 180 days.

Terms

Arbitration

Not independently confirmed this pass — standard binding arbitration + class action waiver expected.

Data sharing

Not independently confirmed this pass with a specific named data-privacy lawsuit or breach; as a primarily B2B/institutional pharmaceutical, medical-device, or lab-equipment manufacturer, most individual consumer exposure is INDIRECT (as a patient using a device/drug prescribed by a provider) rather than through a direct account relationship — recommend checking specifically for any patient-assistance/copay program or connected-device app this company operates, since those are the points where direct consumer data collection would occur.

Fees and billing

Not itemized this pass.

Contacts

Privacy contact. Not recorded.

Legal notice. Not verified this pass. If publicly traded: SEC Form 10-K cover page gives the official corporate address; the Secretary of State business-entity search in the state of incorporation gives the registered agent, which must accept service. If private: the state registered agent is usually the only reliable route.

Mailing address. Not recorded.

No published channel
Paper trail: none. No published channel.

Evidence

No claims have been itemized for this row yet.

No sources are on file for this row yet.

Source vault

Link status: Candidate - not yet fetched

DocumentLast fetchPDF
Privacy policy
See IQVIA's own published privacy policy
Not fetched yetNOT CONFIRMED
Terms of service
See IQVIA's own published terms of service
Not fetched yetNOT CONFIRMED
Website
No URL recorded
Not fetched yet—
Primary source
No URL recorded
Verification: Unverified - heuristic first draft
Not fetched yet—

Enforcement

No enforcement actions are linked to this row.

State statute

No HQ state on file, so no state statute applies by headquarters.